AXSM

Axsome Therapeutics
AXSM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$5.08B
EV
$4.96B
Shares Outstanding
53.46M
Beta
0.88

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$177.35
P/E 2025E
-
P/Revenue 2025E
8.24x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Axsome Therapeutics, Inc.

gainify
AXSM

Axsome Therapeutics, Inc.

AXSM

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl...

Sector

Healthcare

Industry

Biotechnology

CEO

Tabuteau, Herriot

Employees

683

IPO Date

2015-11-19

Headquarters

One World Trade Center, 22nd Floor, New York, New York, 10007, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved